Want to join the conversation?
$PDCO 1Q16 Call: During the quarter, we also signed a definitive agreement for the sale of our Patterson Medical business, while the transaction has not yet closed, but we expect the sale of Patterson Medical to close in the second quarter.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.